[1] |
Hawker GA, Croxford R, Bierman AS, et al. All-cause mortality and serious cardiovascular events in people with hip and knee osteoarthritis: a population based cohort study[J/OL]. PLoS One, 2014, 9(3): e91286. DOI: 10.1016/j.joca.2014.02.089.
|
[2] |
Rehart S, Wickler B, Nitschmann S. Osteoarthritis of the knee: physical therapy or intra-articular corticoid injection[J]. Internist (Berl), 2020, 61(10): 1087-1090.
|
[3] |
李川,卜鹏飞,韩云峰,等.运动治疗膝骨关节炎的实施方案及临床探索[J/CD].中华关节外科杂志(电子版),2021,15(1):98-103.
|
[4] |
Cole BJ, Seroyer ST, Filardo G, et al. Platelet-rich plasma: where are we now and where are we going?[J]. Sports Health, 2010, 2(3): 203-210.
|
[5] |
邢丹,余楠生,袁霆,等.关节腔注射富血小板血浆治疗膝骨关节炎的临床实践指南(2018年版)[J/CD].中华关节外科杂志(电子版),2018,12(4):444-448.
|
[6] |
Görmeli G, Görmeli CA, Ataoglu B, et al. Multiple PRP injections are more effective than single injections and hyaluronic acid in knees with early osteoarthritis: a randomized, double-blind, placebo-controlled trial[J]. Knee Surg Sports Traumatol Arthrosc, 2017, 25(3): 958-965.
|
[7] |
Patel S, Dhillon MS, Aggarwal S, et al. Treatment with platelet-rich plasma is more effective than placebo for knee osteoarthritis: a prospective, double-blind, randomized trial[J]. Am J Sports Med, 2013, 41(2): 356-364.
|
[8] |
Kavadar G, Demircioglu DT, Celik MY, et al. Effectiveness of platelet-rich plasma in the treatment of moderate knee osteoarthritis: a randomized prospective study[J]. J Phys Ther Sci, 2015, 27(12): 3863-3867.
|
[9] |
中华医学会骨科学分会关节外科学组.骨关节炎诊疗指南(2018年版)[J].中华骨科杂志,2018,38(12):705-715.
|
[10] |
袁霆,张长青.骨组织及软组织修复作用中富血小板血浆的制作及其原理[J].中国临床康复,2004,8(35):7939-7941.
|
[11] |
Mohammad S, Rik K. Platelet-rich plasma (PRP) for knee disorders[J]. Efort Open Reviews, 2017, 2(2):28-34.
|
[12] |
Morishita R, Aoki M, Hashiya N, et al. Safety evaluation of clinical gene therapy using hepatocyte growth factor to treat peripheral arterial disease[J]. Hypertension, 2004, 44(2): 203-209.
|
[13] |
王新刚,黄鹏,雷玉凯.超声半定量评估膝关节软骨退变程度与临床表现的相关性分析[J].中国实验诊断学,2020,24(2):272-274.
|
[14] |
Jevsevar DS. Treatment of osteoarthritis of the knee: evidence-based guideline, 2nd edition[J]. J Am Acad Orthop Surg, 2013, 21(9): 571-576.
|
[15] |
Van Buul GM, Koevoet WL, Kops N, et al. Platelet-rich plasma releasate inhibits inflammatory processes in osteoarthritic chondrocytes[J]. Am J Sports Med, 2011, 39(11): 2362-2370.
|
[16] |
Mccarrel T, Fortier L. Temporal growth factor release from platelet-rich plasma, trehalose lyophilized platelets, and bone marrow aspirate and their effect on tendon and ligament gene expression[J]. J Orthop Res, 2009, 27(8): 1033-1042.
|
[17] |
Song S, Cha YD, Han J, et al. Hyaline cartilage regeneration using mixed human chondrocytes and transforming growth factor-beta1- producing chondrocytes[J]. Tissue Eng, 2005, 11(9/10): 1516-1526.
|
[18] |
Chen C, Chen JL, Hsu CC, et al. Injecting autologous platelet rich plasma solely into the knee joint is not adequate in treating geriatric patients with moderate to severe knee osteoarthritis[J]. Exp Gerontol, 2019, 119(5): 1-6.
|
[19] |
齐清华,刘宏建,赵艳萍,等.彩色超微血管成像技术及高频超声在早期幼年特发性关节炎膝关节病变的应用[J].中华实验外科杂志,2018,35(12):2330-2332.
|
[20] |
温朝美.肌骨超声评分系统在类风湿关节炎中的应用[J].中国医学影像技术,2016,32(5):807-810.
|